← Back to Search

Opaque Bottle for Opaque Bottles

N/A
Waitlist Available
Led By Alison K Ventura, PhD
Research Sponsored by California Polytechnic State University-San Luis Obispo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-week period
Awards & highlights

Study Summary

This trial will study whether using a clear or opaque bottle affects how infants are fed.

Eligible Conditions
  • Opaque Bottles
  • Clear Bottles

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-week period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-week period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Infant Intake (mL) During the Observed Feeding
Infant Weight-for-length Z-scores
Maternal Sensitivity to Infant Cues
Secondary outcome measures
Change in Infant Subscapular Skinfolds z-Scores
Change in Infant Triceps Skinfolds z-Scores
Change in Infant Waist Circumference
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Opaque Bottle GroupExperimental Treatment1 Intervention
This group was given a set of opaque bottles to use during infant feedings for a full 12-week period.
Group II: Clear Bottle GroupActive Control1 Intervention
This group was given a set of clear bottles to use during infant feedings for a full 12-week period.

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,963 Previous Clinical Trials
2,674,589 Total Patients Enrolled
California Polytechnic State University-San Luis ObispoLead Sponsor
29 Previous Clinical Trials
3,135 Total Patients Enrolled
Alison K Ventura, PhDPrincipal InvestigatorCalifornia Polytechnic State University-San Luis Obispo
6 Previous Clinical Trials
278 Total Patients Enrolled

Frequently Asked Questions

~24 spots leftby Apr 2025